Single-needle dialysis access device safety and effectiveness study
Part of Kidney & urinary clinical trials.
This study tests a new single-needle device (OnePoint Dialysis Cannula) for hemodialysis patients who currently use two needles. The goal is to see if one needle can work safely and effectively for patients with a healthy, mature vein (arteriovenous fistula or AVF).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and able to come to a dialysis center three times per week
- You have a mature AVF (a surgically created vein connection for dialysis) that has been working well for at least 3 months with two needles
- Your AVF meets specific size and flow requirements: blood flow of at least 500 mL/min, vein diameter of at least 5 mm, depth of 5 mm or less from your skin, and at least 5 cm of usable length
- You have no narrowing (stenosis) or clots (thrombosis) in your AVF, confirmed by ultrasound
- You have not had any active infections in the past 90 days and have not changed blood thinner medications in the past 60 days
- Your dialysis center can collect data and monitor you closely for 30 days during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new single-needle return technique for your dialysis access (AVF) to the usual two-needle method. It aims to see if using just one needle on your fistula and getting the blood back through a leg vein can help your fistula last longer.
This study compares two ways to create access for dialysis in patients aged 60 or older (or younger with multiple health conditions). You'll either receive a tunneled catheter placed in your chest or neck, or have surgery to create a fistula (direct connection between an artery and vein in your arm) to help with dialysis treatment.
This trial tests a small implant device that can make dialysis fistulas easier to access with needles when normal needle access is too difficult or risky. It may help reduce painful failed attempts and needle-related complications for people with certain types of fistulas.
This trial tests a new device called the Velocity pAVF System that creates a connection between a vein and artery in your arm for hemodialysis. If you need dialysis now or within the next 6 months, this could be a new option for you.
This study tests a device that uses light to check the health of your AV access (the blood vessel connection used for dialysis) without touching it. It may help doctors spot problems early.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
Hear when a new Vascular Access trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.